These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 6273181)

  • 1. Purification and characterization of an immunosuppressive factor from ovarian cancer ascites fluid.
    Oh SK; Moolten FL
    Eur J Immunol; 1981 Oct; 11(10):780-8. PubMed ID: 6273181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonspecific immunosuppressive factors in malignant ascites: further characterization and possible relationship to erythrocyte receptors of human peripheral T cells.
    Oh SK; Moolten FL
    J Immunol; 1981 Dec; 127(6):2300-7. PubMed ID: 6975316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alpha-1 acid glycoprotein is an immunosuppressive factor found in ascites from ovaria carcinoma.
    Elg SA; Mayer AR; Carson LF; Twiggs LB; Hill RB; Ramakrishnan S
    Cancer; 1997 Oct; 80(8):1448-56. PubMed ID: 9338469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An analogy between fetal haptoglobin and a potent immunosuppressant in cancer.
    Oh SK; Very DL; Walker J; Raam S; Ju ST
    Cancer Res; 1987 Oct; 47(19):5120-6. PubMed ID: 3621198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of an immunosuppressive factor from malignant ascites that resembles a factor induced in vitro by carcinoembryonic antigen.
    Medoff JR; Clack VD; Roche JK
    J Immunol; 1986 Sep; 137(6):2057-64. PubMed ID: 3528293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Purification and biological characterization of human hepatopoietin A, a polypeptide growth factor for hepatocytes.
    Zarnegar R; Michalopoulos G
    Cancer Res; 1989 Jun; 49(12):3314-20. PubMed ID: 2524251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolation and characterization of an immunosuppressive acidic protein from ascitic fluids of cancer patients.
    Tamura K; Shibata Y; Matsuda Y; Ishida N
    Cancer Res; 1981 Aug; 41(8):3244-52. PubMed ID: 6166371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential effects of an immunosuppressive fraction from ascites fluid of patients with ovarian cancer on spontaneous and antibody-dependent cytotoxicity.
    Badger AM; Oh SK; Moolten FR
    Cancer Res; 1981 Mar; 41(3):1133-9. PubMed ID: 7193084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Partial characterization of a T cell-derived factor that suppresses the initiation of the humoral immune response in vitro.
    Douglas GN; Rubin AS
    Immunology; 1977 Nov; 33(5):745-55. PubMed ID: 338477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biological expressions of lymphocyte activation. V. Characterization of a soluble immune response suppressor (SIRS) produced by concanavalin A-activated spleen cells.
    Tadakuma T; Kühner AL; Rich RR; David JR; Pierce CW
    J Immunol; 1976 Jul; 117(1):323-30. PubMed ID: 6595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Purification and partial characterization of a preneoplastic antigen in liver carcinogenesis.
    Lin JC; Kligman L; Farber E
    Cancer Res; 1980 Oct; 40(10):3755-62. PubMed ID: 7438059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The subunit structure of normal and hemophilic factor VIII.
    Shapiro GA; Andersen JC; Pizzo SV; McKee PA
    J Clin Invest; 1973 Sep; 52(9):2198-210. PubMed ID: 4199414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of macrophage migration by a factor from ascites fluids of ovarian cancer patients. I. Biochemical characterization and purification.
    Fahlbusch B; Tittel R
    Biomed Biochim Acta; 1986; 45(3):359-70. PubMed ID: 3518710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-affinity folate receptor in human ovary, serous ovarian adenocarcinoma, and ascites: radioligand binding mechanism, molecular size, ionic properties, hydrophobic domain, and immunoreactivity.
    Holm J; Hansen SI; Høier-Madsen M; Birn H; Helkjaer PE
    Arch Biochem Biophys; 1999 Jun; 366(2):183-91. PubMed ID: 10356282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acid stable protease inhibitor in ascites of ovarian carcinoma.
    Akazawa K; Sumi H; Maruyama M; Mihara H
    Clin Chim Acta; 1983 Jun; 131(1-2):87-99. PubMed ID: 6411386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum lipoproteins and apolipoproteins in rats with streptozotocin-induced diabetes.
    Bar-On H; Roheim PS; Eder HA
    J Clin Invest; 1976 Mar; 57(3):714-21. PubMed ID: 175093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biochemical and immunologic characterization of galactosyltransferase purified from the ascites of ovarian cancer patients.
    Chatterjee SK; Bhattacharya M; Barlow JJ
    J Natl Cancer Inst; 1985 Aug; 75(2):237-48. PubMed ID: 3927048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Purification and characterization of corresponding antigen recognized by monoclonal antibody 183B2 against ovarian carcinoma].
    Guo HF; Feng J; Zhang H; Yao Y; Cheng HY
    Zhonghua Fu Chan Ke Za Zhi; 2005 Sep; 40(9):614-8. PubMed ID: 16202318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Purification and some properties of "Clostridium perfringens" delta toxin (author's transl)].
    Tixier G; Alouf JE
    Ann Microbiol (Paris); 1976; 127B(4):509-24. PubMed ID: 192118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Purification and partial characterization of a thrombin-like/gyroxin enzyme from bushmaster (Lachesis muta rhombeata) venom.
    Aguiar AS; Alves CR; Melgarejo A; Giovanni-de-Simone S
    Toxicon; 1996 May; 34(5):555-65. PubMed ID: 8783450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.